Keyphrases
High-risk Human Papillomavirus (HR-HPV)
100%
Head-and-neck
100%
Second Primary
100%
Neck Malignancy
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
73%
Second Primary Malignancy
66%
High Risk
20%
Confidence Interval
13%
Adjusted Hazard Ratio
13%
Malignancy Development
13%
Multivariable
6%
Patient Outcomes
6%
Overall Survival
6%
Cox Proportional Hazards Model
6%
Patient Characteristics
6%
Prevention Strategies
6%
Retrospective Cohort Analysis
6%
Laryngoscope
6%
Risk of Death
6%
Cancer Diagnosis
6%
Index Cancer
6%
Grey Model
6%
Competing-risks Regression Model
6%
Secondary Disease Prevention
6%
Cox Proportional Hazards Regression Model
6%
Fine Model
6%
Long-stay Patients
6%
Subsequent Primary Cancer
6%
Medicine and Dentistry
Cancer
100%
Neck
100%
Wart Virus
100%
Head and Neck Squamous Cell Carcinoma
73%
Second Cancer
66%
Hazard Ratio
13%
Proportional Hazards Model
13%
Overall Survival
6%
Primary Tumor
6%
Cancer Diagnosis
6%
Cohort Analysis
6%
Retrospective Study
6%
Prophylaxis
6%
Psychology
Relatedness
100%
Proportional Hazards Regression Model
66%
Hazard Ratio
66%
Study Design
33%
Regression Model
33%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus
100%
Head and Neck Squamous Cell Carcinoma
73%
Second Cancer
66%
Disease
6%
Malignant Neoplasm
6%
Primary Tumor
6%
Overall Survival
6%
Retrospective Study
6%